Valneva SE (VALN) Other Operating Expenses (2021 - 2026)

Valneva SE's (VALN) quarterly Other Operating Expenses came in at $2.3 million in Q1 2026, little changed year-on-year from $2.3 million in Q1 2025, and down 81.3% quarter-over-quarter from $12.1 million in Q4 2025.

Valneva SE (VALN) Other Operating Expenses (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Other Operating Expenses across 6 years of filings, most recently posting $2.3 million for Q1 2026.

  • Other Operating Expenses for Q1 2026 came in at $2.3 million, changed 0.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.9 million (down 49.55% YoY), and the FY2025 annual result was $12.1 million, down 45.29% from the prior year.
  • Other Operating Expenses came in at $2.3 million for Q1 2026 at Valneva SE, down from $12.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $116.1 million in Q3 2024 to a low of -$101.0 million in Q2 2024.
  • The 5-year median for Other Operating Expenses is $3.5 million (2024), against an average of $4.7 million.
  • Peak annual rise in Other Operating Expenses reached 861.03% in 2024, while the deepest fall reached 980.72% in 2024.
  • Valneva SE's Other Operating Expenses stood at $4.8 million in 2022, then soared by 380.11% to $23.2 million in 2023, then sank by 73.16% to $6.2 million in 2024, then surged by 94.79% to $12.1 million in 2025, then slumped by 81.3% to $2.3 million in 2026.
  • The last three Other Operating Expenses figures came in at $2.3 million (Q1 2026), $12.1 million (Q4 2025), and -$2.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.26 Mn
Dec 31, 2025 12.11 Mn
Jun 30, 2025 -2.45 Mn
Mar 31, 2025 2.27 Mn
Dec 31, 2024 6.21 Mn
Sep 30, 2024 116.11 Mn
Jun 30, 2024 -100.96 Mn
Mar 31, 2024 3.17 Mn
Dec 31, 2023 23.15 Mn
Sep 30, 2023 -15.26 Mn
Jun 30, 2023 11.46 Mn
Mar 31, 2023 3.74 Mn
Dec 31, 2022 4.82 Mn
Sep 30, 2022 3.91 Mn
Jun 30, 2022 1.61 Mn
Mar 31, 2022 2.34 Mn
Dec 31, 2021 7.94 Mn
Sep 30, 2021 6.66 Mn
Jun 30, 2021 8.92 Mn
Mar 31, 2021 3.59 Mn